ValiRx plc (LON:VAL – Get Free Report)’s stock price was down 1.7% during trading on Monday . The company traded as low as GBX 0.16 and last traded at GBX 0.18. Approximately 12,977,390 shares changed hands during trading, an increase of 32% from the average daily volume of 9,839,466 shares. The stock had previously closed at GBX 0.18.
ValiRx Stock Down 1.7%
The company’s fifty day simple moving average is GBX 0.23 and its 200-day simple moving average is GBX 0.30. The company has a debt-to-equity ratio of 0.19, a current ratio of 9.66 and a quick ratio of 1.27. The firm has a market capitalization of £1.31 million, a PE ratio of -0.19 and a beta of 0.59.
ValiRx (LON:VAL – Get Free Report) last posted its quarterly earnings data on Monday, June 22nd. The company reported GBX (0.54) earnings per share for the quarter. ValiRx had a negative return on equity of 45.91% and a negative net margin of 3,582.56%.The business had revenue of GBX 3 million during the quarter. On average, analysts forecast that ValiRx plc will post -1.74 EPS for the current year.
About ValiRx
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Featured Stories
- Five stocks we like better than ValiRx
- Buy CrowdStrike Before the Stock Split? Here’s the Case
- Investors Are Buying Into Sweetgreen Again—Should They?
- Burlington Is Winning Over Shoppers But Investors Need Patience
- USA Today’s Digital Revival Is Gaining Steam, But With Plenty of Risk
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
